Literature DB >> 23513566

Guidelines for chemotherapy of pulmonary nontuberculous mycobacterial disease--2012 revised version.

.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23513566

Source DB:  PubMed          Journal:  Kekkaku        ISSN： 0022-9776


× No keyword cloud information.
  7 in total

1.  A case of membranoproliferative glomerulonephritis and AA amyloidosis complicated with pulmonary nontuberculous mycobacterial infection.

Authors:  Kiyokazu Tsuji; Hideyuki Arai; Akira Furusu; Kenta Torigoe; Ayuko Tokuyama; Yoshiaki Muraya; Masahiro Nakashima; Takashi Taguchi; Yoko Obata; Tomoya Nishino; Shigeru Kohno
Journal:  CEN Case Rep       Date:  2014-07-09

Review 2.  Surgical treatment of nontuberculous mycobacterial lung disease.

Authors:  Yuji Shiraishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-17

3.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

4.  Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol.

Authors:  Taku Nakagawa; Hiroya Hashimoto; Mitsuaki Yagi; Yoshihito Kogure; Masahiro Sekimizu; Akiko M Saito; Kenji Ogawa; Yoshikazu Inoue
Journal:  BMJ Open Respir Res       Date:  2019-05-30

5.  Mortality in rheumatoid arthritis patients with pulmonary nontuberculous mycobacterial disease: A retrospective cohort study.

Authors:  Shunsuke Mori; Yukinori Koga; Kazuyoshi Nakamura; Sayuri Hirooka; Takako Matsuoka; Hideshi Uramoto; Osamu Sakamoto; Yukitaka Ueki
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

6.  Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes.

Authors:  Hitoshi Shimomura; Sena Andachi; Takahiro Aono; Akira Kigure; Yosuke Yamamoto; Atsushi Miyajima; Takashi Hirota; Keiko Imanaka; Toru Majima; Hidenori Masuyama; Koichiro Tatsumi; Takao Aoyama
Journal:  J Pharm Health Care Sci       Date:  2015-11-14

7.  Clinical Aspects of Pulmonary Nontuberculous Mycobacteriosis.

Authors:  Hiroshi Moro; Toshiaki Kikuchi
Journal:  Intern Med       Date:  2021-04-12       Impact factor: 1.271
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.